FPH provides Investor Event presentation

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)

Fisher & Paykel Healthcare provides Investor Event presentation

Auckland, New Zealand, 23 July 2025 – Fisher & Paykel Healthcare Corporation Limited attaches
a copy of its presentation to analysts and investors for its Investor Event held today in Melbourne,
Australia.

There is no new material information contained within the presentation.

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and
systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive
sleep apnea. The company’s products are sold in over 120 countries worldwide. For more
information about the company, visit our website www.fphcare.com.

Contacts:

Media Investors
Karen Knott
GM Corporate Communications
karen.knott@fphcare.co.nz
+64 21 713 911
Dan Adolph
Head of Investor Relations
daniel.adolph@fphcare.co.nz
+64 22 511 4050

Authorised by Raelene Leonard, General Counsel and Company Secretary.

---

1
2
3
4

0%
10%
20%
30%
40%
50%
60%
70%
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24*FY25
Long-term gross margin target
*Underlying gross margin excludes the product recall provision

1
2
3
4

Applications outside of invasive ventilation
Surgical
Home Respiratory
Support
Obstructive Sleep
Apnea
Noninvasive
Ventilation
Invasive
Ventilation
Hospital
Respiratory Support
Infant Care
Anesthesia

The image above is an illustration of the company’s long-term growth aspirations. It is not a graph and should not be interpreted as being
indicative of levels of revenue or profitability in the short term.

1
2
3
4

1
2
3
4

1

2

3

4

Editor-in-chief Prof. Hugh Hemmings
-
-
-

*
Nasal high flow (NHF)
is acknowledged
and/or recommended
alongside other
oxygenation
techniques

1
2
3
4